The latest quarterly R&D expense is $27.13 Million with a QoQ Growth of +3.55%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $27.13M.
$27.13M
$27.13 Million
Q2 FY2026 · 2026-06-30
+3.55%
vs. $26.20M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $27.13M | +3.55% | +5.13% |
| Q1 FY2026Period end 2026-03-31 | $26.20M | +5.47% | +5.83% |
| Q4 FY2025Period end 2025-12-31 | $24.84M | +8.72% | +21.81% |
| Q3 FY2025Period end 2025-09-30 | $22.85M | -11.46% | +16.90% |
| Q2 FY2025Period end 2025-06-30 | $25.80M | +4.24% | +63.97% |
| Q1 FY2025Period end 2025-03-31 | $24.76M | +21.39% | +66.39% |
| Q4 FY2024Period end 2024-12-31 | $20.39M | +4.34% | +60.42% |
| Q3 FY2024Period end 2024-09-30 | $19.55M | +24.19% | +52.62% |
| Q2 FY2024Period end 2024-06-30 | $15.74M | +5.78% | +34.10% |
| Q1 FY2024Period end 2024-03-31 | $14.88M | +17.03% | +4.89% |
| Q4 FY2023Period end 2023-12-31 | $12.71M | -0.73% | -40.95% |
| Q3 FY2023Period end 2023-09-30 | $12.81M | +9.12% | -33.83% |
| Q2 FY2023Period end 2023-06-30 | $11.74M | -17.26% | -37.78% |
| Q1 FY2023Period end 2023-03-31 | $14.18M | -34.11% | -14.81% |
| Q4 FY2022Period end 2022-12-31 | $21.53M | +11.24% | +31.52% |
| Q3 FY2022Period end 2022-09-30 | $19.35M | +2.60% | +34.91% |
| Q2 FY2022Period end 2022-06-30 | $18.86M | +13.29% | +34.51% |
| Q1 FY2022Period end 2022-03-31 | $16.65M | +1.72% | N/A |
| Q4 FY2021Period end 2021-12-31 | $16.37M | +14.11% | N/A |
| Q3 FY2021Period end 2021-09-30 | $14.34M | +2.29% | N/A |
| Q2 FY2021Period end 2021-06-30 | $14.02M | N/A | N/A |
| Q4 FY2020Period end 2020-12-31 | $13.58M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
